Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession
- PMID: 23273573
- PMCID: PMC3596471
- DOI: 10.1016/j.neurobiolaging.2012.11.020
Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession
Erratum in
- Neurobiol Aging. 2013 Sep;34(9):e3
Abstract
Impaired brain energy metabolism and oxidative stress are implicated in cognitive decline and the pathologic accumulations of amyloid β-peptide (Aβ) and hyperphosphorylated tau in Alzheimer's disease (AD). To determine whether improving brain energy metabolism will forestall disease progress in AD, the impact of the β-nicotinamide adenine dinucleotide precursor nicotinamide on brain cell mitochondrial function and macroautophagy, bioenergetics-related signaling, and cognitive performance were studied in cultured neurons and in a mouse model of AD. Oxidative stress resulted in decreased mitochondrial mass, mitochondrial degeneration, and autophagosome accumulation in neurons. Nicotinamide preserved mitochondrial integrity and autophagy function, and reduced neuronal vulnerability to oxidative/metabolic insults and Aβ toxicity. β-Nicotinamide adenine dinucleotide biosynthesis, autophagy, and phosphatidylinositol-3-kinase signaling were required for the neuroprotective action of nicotinamide. Treatment of 3xTgAD mice with nicotinamide for 8 months resulted in improved cognitive performance, and reduced Aβ and hyperphosphorylated tau pathologies in hippocampus and cerebral cortex. Nicotinamide treatment preserved mitochondrial integrity, and improved autophagy-lysosome procession by enhancing lysosome/autolysosome acidification to reduce autophagosome accumulation. Treatment of 3xTgAD mice with nicotinamide resulted in elevated levels of activated neuroplasticity-related kinases (protein kinase B [Akt] and extracellular signal-regulated kinases) and the transcription factor cyclic adenosine monophosphate (AMP) response element-binding protein in the hippocampus and cerebral cortex. Thus, nicotinamide suppresses AD pathology and cognitive decline in a mouse model of AD by a mechanism involving improved brain bioenergetics with preserved functionality of mitochondria and the autophagy system.
Published by Elsevier Inc.
Figures
Similar articles
-
Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models.Neurobiol Aging. 2013 Jun;34(6):1581-8. doi: 10.1016/j.neurobiolaging.2012.12.005. Epub 2013 Jan 9. Neurobiol Aging. 2013. PMID: 23312803 Free PMC article.
-
Therapeutic effect of nicotinamide mononucleotide on Alzheimer's disease through activating autophagy and anti-oxidative stress.Biomed Pharmacother. 2024 Sep;178:117199. doi: 10.1016/j.biopha.2024.117199. Epub 2024 Jul 24. Biomed Pharmacother. 2024. PMID: 39053426
-
A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons.J Neurosci. 2012 Apr 25;32(17):5821-32. doi: 10.1523/JNEUROSCI.6192-11.2012. J Neurosci. 2012. PMID: 22539844 Free PMC article.
-
Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.Prog Neurobiol. 2013 Jul-Aug;106-107:33-54. doi: 10.1016/j.pneurobio.2013.06.002. Epub 2013 Jul 1. Prog Neurobiol. 2013. PMID: 23827971 Review.
-
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488. Cells. 2019. PMID: 31121890 Free PMC article. Review.
Cited by
-
Optical Redox Imaging of Ex Vivo Hippocampal Tissue Reveals Age-Dependent Alterations in the 5XFAD Mouse Model of Alzheimer's Disease.Metabolites. 2022 Aug 25;12(9):786. doi: 10.3390/metabo12090786. Metabolites. 2022. PMID: 36144191 Free PMC article.
-
Pandanus amaryllifolius Exhibits In Vitro Anti-Amyloidogenic Activity and Promotes Neuroprotective Effects in Amyloid-β-Induced SH-SY5Y Cells.Nutrients. 2022 Sep 24;14(19):3962. doi: 10.3390/nu14193962. Nutrients. 2022. PMID: 36235616 Free PMC article.
-
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.Signal Transduct _target Ther. 2020 Oct 7;5(1):227. doi: 10.1038/s41392-020-00311-7. Signal Transduct _target Ther. 2020. PMID: 33028824 Free PMC article. Review.
-
The NAD+-mitophagy axis in healthy longevity and in artificial intelligence-based clinical applications.Mech Ageing Dev. 2020 Jan;185:111194. doi: 10.1016/j.mad.2019.111194. Epub 2019 Dec 5. Mech Ageing Dev. 2020. PMID: 31812486 Free PMC article.
-
Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.Metab Brain Dis. 2018 Dec;33(6):1911-1921. doi: 10.1007/s11011-018-0297-0. Epub 2018 Jul 27. Metab Brain Dis. 2018. PMID: 30054774
References
-
- Arias C, Montiel T, Quiroz-Báez R, Massieu L. β-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in Vivo and in isolated nerve terminals: Implications for Alzheimer's disease. Exp. Neurol. 2002;176:163–174. - PubMed
-
- Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Gräber S, Kovacs I, Lee WD, Waggoner J, Cui J, White AD, Bossy B, Martinou JC, Youle RJ, Lipton SA, Ellisman MH, Perkins GA, Bossy-Wetzel E. Nitric oxide-induced mitochondrial fission is regulated by dynamin related GTPases in neurons. EMBO J. 2006;25:3900–3911. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous